CoChat

Clinical and Postoperative Applications of Manuka Honey in Wound Healing: An Evidence‐Based Review

Open access
Alhabsi, Ayman N., Al Lawati, Abdullah, Al Hashmi, Lubna, Al‐Isaii, Fatema, Alghammari, Alwaleed, Das, Srijit, Al Hashmi, Sheikhan · 2026 · International Wound Journal

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index; none of the 97 sources its claims cite is checked for support yet.

Abstract

Chronic and postoperative wounds remain challenging to manage, with high risks of infection, delayed healing and increased costs. Manuka honey offers antibacterial, anti‐inflammatory, antioxidant and tissue‐regenerative properties through methylglyoxal, phenolic compounds, high sugar content and low pH. The main objective is to review the mechanisms, clinical outcomes and applications of Manuka honey in wound care. A narrative review of PubMed, Scopus and Google Scholar identified studies on surgical site management, graft or flap bed preparation, chronic wounds and novel delivery systems, prioritising randomised controlled trials and high‐quality observational data. Results have shown that Manuka honey demonstrates broad‐spectrum antimicrobial and antibiofilm effects, supports non‐traumatic debridement and modulates inflammation to promote granulation and re‐epithelialisation. Clinical studies show reduced bacterial load, faster healing and improved comfort in surgical and chronic wounds. Operative uses include pre‐grafting bed conditioning, adjunctive treatment for infected wounds and integration with negative pressure wound therapy. Emerging delivery approaches, such as bioengineered honey–collagen dressings and nanofibrous scaffolds, show promise for enhancing postoperative outcomes. To conclude, Manuka honey is a versatile and promising adjunct in modern wound care management. Standardised application protocols and robust, high‐quality surgical trials are urgently needed to confirm its effective role in perioperative clinical practice.

Overview

CoChat Summary

TL;DR

This narrative review synthesizes mechanisms and clinical evidence for medical-grade Manuka honey in chronic and postoperative wound care, reporting antimicrobial, antibiofilm, debridement, immunomodulatory, and regenerative effects. It concludes Manuka honey is a promising adjunct, but standardised application protocols and robust surgical trials are needed.

Key findings

  • Across RCTs, Manuka honey dressings improved some outcomes: in neuropathic diabetic foot ulcers, faster healing (31 ± 4 vs 43 ± 3 days, p < 0.05) and higher week-1 sterilisation (78.1% vs 35.5%); in another DFU trial, fewer toe amputations (9.7% vs 34.6%, p < 0.05) and higher complete healing at 6 weeks and 6 months (p < 0.05).
  • In critically ill children with pressure injuries, median healing time was 7 days (95% CI 6–7) vs 9 days (7–10) with standard care (p = 0.002); in sloughy venous leg ulcers, MRSA was eradicated in 70% of honey-treated wounds vs 16% with hydrogel after 4 weeks.
  • Not all trials showed superiority: a VLU multicentre RCT found complete healing in 55.6% with honey vs 49.7% with usual care at 12 weeks (absolute increase 5.9%, 95% CI −4.3 to 15.7, p = 0.258); a toenail surgery RCT found mean healing 40.3 vs 39.98 days.
  • Emerging delivery systems showed promise: a bioengineered collagen Manuka honey/hydroxyapatite sheet closed chronic wounds in 7.4 weeks vs 14.8 weeks with standard care (p < 0.05); Manuka honey microneedles killed MRSA at honey concentrations ≥ 10%, with vacuum-prepared honey killing up to 8 × 10^7 CFU/mL.

Methods

  • Narrative review with a structured literature search of PubMed/MEDLINE, Scopus, and Google Scholar using terms for Manuka honey, medical-grade honey, Leptospermum, Medihoney, methylglyoxal/MGO, UMF, and wound-related terms; reference lists of key articles were screened.
  • Search covered 1980–2025, prioritising the last 5 years; after duplicate removal, titles and abstracts were screened. Non-English publications, conference abstracts, editorials, and case reports were excluded; animal-only studies were excluded unless they provided mechanistic insights directly relevant to human wound healing.
  • Eligible studies included randomised controlled trials, observational studies, mechanistic investigations, and high-quality reviews, with emphasis on human clinical outcomes in chronic and postoperative wounds; preclinical studies were included selectively for mechanistic context.

Limitations

  • Stated: heterogeneity across RCTs in sample sizes, wound types, honey concentrations, treatment durations, and outcome measures; no universally accepted guidelines on dosing, formulation, or application frequency; limited high-quality RCTs, small samples, lack of long-term follow-up, and some studies conducted more than a decade ago; underrepresentation of geriatric and immunocompromised patients; medical-grade processing cost and clinician training/access barriers, particularly in low-income countries.
  • Stated: regulatory gaps for commercial Manuka honey, including mislabelling, fraud, and adulteration, and the need for standardisation; safety concerns are minimal but unsterilised honey may contain Bacillus and Clostridium spores, with gamma irradiation up to 25 kGy used to sterilise without compromising antimicrobial activity.
  • Evident from the text: as a narrative review, there is no systematic risk-of-bias assessment or quantitative synthesis; evidence includes in vitro, animal, and preclinical data plus case reports/series, and several RCTs report no significant differences, so conclusions rely on mixed evidence.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1111/iwj.70939

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIGURE 1 Key bioactive components of Manuka honey and their plant/nectar origins. Created with biorender.com.
FIGURE 1 Key bioactive components of Manuka honey and their plant/nectar origins. Created with biorender.com.CC BY-NC · PubMed Central
FIGURE 2 Mechanisms of Manuka honey with wound healing. Created with biorender.com.
FIGURE 2 Mechanisms of Manuka honey with wound healing. Created with biorender.com.CC BY-NC · PubMed Central

Verification

Claims the paper makes

0 Valid · 1 Not valid · 77 Not checked · 20 Own results and interpretations

39 more claims

Create a free account to see all 98 claims and to verify the 94 references still open.

See all claims — free account
  • It may state two separate claims as one. 49
  • Probably not a substantial claim. 6

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 5

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Research works printed but not linked: 2

  1. M. R. Barer, W. L. Irving, A. Swann, and N. Perera, Medical Microbiology: A Guide to Microbial Infections: Pathogenesis, Immunity, Laboratory Investigation and Control, 19th ed. (Churchill Livingstone Elsevier, 2018).
  2. V. Kumar, A. K. Abbas, and J. C. Aster, Robbins and Cotran Pathologic Basis of Disease, 10th ed. (Elsevier, 2020).

Cited by

See all 4

Metadata

Authors
Alhabsi, A. N., Al Lawati, A., Al Hashmi, L., Al‐Isaii, F., Alghammari, A., Das, S., & Al Hashmi, S.
Affiliations
  • Royal College of Surgeons in Ireland (IE)
  • Department of Surgery Sultan Qaboos University Hospital Muscat Oman
  • Department of Plastic, Craniofacial and Burn surgery Khoula Hospital Muscat Oman
  • Sultan Qaboos University (OM)
Corresponding author
Alhabsi, Ayman N.
Venue
International Wound Journal
Publisher
Wiley
Published
2026-05
Volume
23
Issue
5
Pages
e70939-e70939
ISSN
  • 1742-4801 (ISSN-L)
  • 1742-481X
OpenAlex
W7160953827
Cited by
4
References
81
Citations by year
2026: 4
FWCI
2.70
Type
journal article
Language
en
Open access
Licence
Locations
  • International Wound Journal (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Insect Science › Bee Products Chemical Analysis
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
Keywords
manuka honey, wound healing, chronic wounds, postoperative wound care, surgical site infection, methylglyoxal, antibiofilm activity, debridement, negative pressure wound therapy, nanofibrous scaffolds, re-epithelialization, granulation tissue
MeSH terms
Honey, Humans, Surgical Wound Infection, Wound Healing, Wounds and Injuries, Leptospermum

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.